Artivion, Inc. Common Stock AORT 深 滬
已收盤 10-03 16:00:00 美东时间
41.05
+0.460
+1.13%
華盛通- 最 高41.59
- 今 開40.90
- 成交量 26.40万股
- 最 低 40.80
- 昨 收 40.59
- 總市值 19.37亿
- 52周最高 45.07
- 市盈率 靜 --
- 換手率 0.56%
- 52周最低 21.97
- 委 比 50.00%
- 總股本 4718.37万
- 歷史最高 45.07
- 量 比 0.65
- 振 幅 1.95%
- 歷史最低 3.82
- 每 手 1
- 風險率 5.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
Artivion To Acquire 1300 East Anderson Lane Property For $12.05M And 1200 East Anderson Lane Property For $8.45M
On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having substantially similar material terms, except as noted otherwise herein. The first agreement is
09-30 04:48
Artivion Expands with Austin Property Acquisitions
Artivion ( ($AORT) ) has issued an announcement. On September 26, 2025, Artivio...
09-30 04:45
Beyond The Numbers: 7 Analysts Discuss Artivion Stock
Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinions spanning from bullish to bearish.
09-29 21:10
Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $50
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $41 to $50.
09-29 20:13
Artivion Amends Credit Agreement to Extend Loan Terms
Artivion ( ($AORT) ) has provided an update. On September 12, 2025, Artivion, I...
09-15 20:20
Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
ATLANTA, Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the ...
09-06 04:10
Needham Maintains Buy on Artivion, Raises Price Target to $50
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.
08-22 19:11
Artivion Appoints Lance A. Berry as COO
Artivion ( ($AORT) ) has shared an update. On August 6, 2025, Artivion, Inc. an...
08-12 01:47
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
